These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37754231)

  • 1. Long Noncoding RNA TALAM1 Is a Transcriptional Target of the RUNX2 Transcription Factor in Lung Adenocarcinoma.
    Bermúdez G; Bernal C; Otalora A; Sanchez P; Nardocci G; Cañas A; Lopez-Kleine L; Montecino M; Rojas A
    Curr Issues Mol Biol; 2023 Aug; 45(9):7075-7086. PubMed ID: 37754231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
    Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
    Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MALAT1 sponges miR-30 to promote osteoblast differentiation of adipose-derived mesenchymal stem cells by promotion of Runx2 expression.
    Yi J; Liu D; Xiao J
    Cell Tissue Res; 2019 Apr; 376(1):113-121. PubMed ID: 30511267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Role of the RUNX2 Transcription Factor in Lung Cancer Apoptosis.
    Bernal C; Otalora A; Cañas A; Barreto A; Prieto K; Montecino M; Rojas A
    Int J Cell Biol; 2022; 2022():5198203. PubMed ID: 36510562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism.
    Yang DP; Huang WY; Chen G; Chen SW; Yang J; He RQ; Huang SN; Gan TQ; Ma J; Yang LJ; Song JH; Mo JX; Tang ZQ; Li CB; Zhou HF; Kong JL
    Comput Biol Chem; 2020 Dec; 89():107383. PubMed ID: 33032037
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
    J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells.
    Tandon M; Gokul K; Ali SA; Chen Z; Lian J; Stein GS; Pratap J
    Mol Cancer; 2012 Jun; 11():27. PubMed ID: 22537242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
    Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
    Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer.
    Ma F; Xie Y; Lei Y; Kuang Z; Liu X
    BMC Cancer; 2020 Jun; 20(1):580. PubMed ID: 32571328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
    Terashima M; Tange S; Ishimura A; Suzuki T
    J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
    Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Manfredi M; Marengo E; Brandi J; Cecconi D; Mori A; Mina MM; Antoniazzi F; Mottes M; Tiso N; Malerba G; Zipeto D; Valenti MT
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of skeletal development by the Runx family of transcription factors.
    Komori T
    J Cell Biochem; 2005 Jun; 95(3):445-53. PubMed ID: 15786491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
    Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
    Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX2 stabilization by long non-coding RNAs contributes to hypertrophic changes in human chondrocytes.
    Yoon DS; Kim EJ; Cho S; Jung S; Lee KM; Park KH; Lee JW; Kim SH
    Int J Biol Sci; 2023; 19(1):13-33. PubMed ID: 36594090
    [No Abstract]   [Full Text] [Related]  

  • 17. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
    Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
    J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
    Zhuo W; Hu D; Chen X; Zhang T
    Mol Med Rep; 2019 Jun; 19(6):5275-5280. PubMed ID: 31059049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MALAT1 sponges miR-30c to promote the calcification of human vascular smooth muscle cells by regulating Runx2.
    Gong Y; Zhong Q; Xia Y; Wen Y; Gan H
    Ren Fail; 2023 Dec; 45(1):2204953. PubMed ID: 37125614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.
    Mendoza-Villanueva D; Deng W; Lopez-Camacho C; Shore P
    Mol Cancer; 2010 Jun; 9():171. PubMed ID: 20591170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.